Eurekan Biotechnologies (EureBIO) was conceived in "Archimedic - Ecstasy" in September 2005 by an aspiring young scientist - Olumide Adenmosun.
It was primarily born out of a deep quest to help strengthen the collaborative reins of the current global work force in research medicine to combat the scourge of diseases
such as HIV/AIDS, Tuberculosis, Malaria, Sickle Cell Anemia and many more - ravaging the African continent and the entire world at large.
Our three-tier objectives at present focuses on:
Building the intellectual capacity of young scientists with informative trends, problem-solving skills and unexplored innovativeness on pressing world health needs.
Subjecting the proposed innovations to enhanced biomedical researches where they are extensively analyzed and acceptable results are presented - to further validate the intellectual properties which were previously mere thoughts.
Channeling the validated intellectual properties to industrial inventions which can be seen, handled and used to combat the actual health needs that initially arose.